Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06OFZ
|
|||
| Former ID |
DIB014608
|
|||
| Drug Name |
LEISH-F1
|
|||
| Synonyms |
LeIF adjuvant, Corixa; Leish-111f; Leishmanial eukaryotic initiation factor, Corixa; Leishmaniasis vaccine (LeIF), Corixa; Leishmaniasis vaccine, Corixa/ Infectious Disease Research Institute; Vaccine (leishmania), Corixa; LeIF enhanced T-cell vaccine, Corixa, Infectious Disease Research Institute
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Leishmania infection [ICD-11: 1F54.0; ICD-10: B55.0] | Phase 2 | [1] | |
| Company |
Infectious Disease Research Institute
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An overview on Leishmania vaccines: A narrative review article. Vet Res Forum. 2015 Winter;6(1):1-7. | |||
| REF 2 | A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine. 2011 Apr 27;29(19):3531-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.